Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
Conditions:   Coronary Artery Disease;   Cardiovascular Diseases;   Coronary Disease;   Myocardial Ischemia;   Arteriosclerosis;   Vascular Disease Occlusive Interventions:   Procedure: VRS100 robotic-assisted PCI;   Procedure: Manual PCI Sponsors:   Shenzhen Raysight Intelligent Medical Technology Co., Ltd.;   Shanghai Zhongshan Hospital;   West China Hospital;   Shenzhen People's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

MK-0616 (Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015)
Conditions:   Arteriosclerosis;   Hypercholesterolaemia Interventions:   Drug: MK-0616;   Drug: Placebo Sponsor:   Merck Sharp & Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials